Literature DB >> 14727181

Genetics of parkin-linked disease.

Andrew B West1, Nigel T Maidment.   

Abstract

Research into Parkinson's disease (PD), once considered the archetypical non-genetic neurodegenerative disorder, has been revolutionized by the identification of a number of genes, mutations of which underlie various familial forms of the disease. Whereas such mutations appear to exist in a relatively small number of individuals from a few families, the study of the function of these genes promises to reveal the fundamental disease pathogenesis, not only of familial forms of the disease, but also of the much more common sporadic PD. The observation that mutations in the second identified PD locus (parkin) are common in juvenile- and early-onset PD and increasing evidence supporting a direct role for parkin in late-onset disease make this gene a particularly compelling candidate for intensified investigation. The determination of the frequency and effect of parkin mutations in various subsets of PD will be crucial for understanding the way in which parkin is related to neurodegenerative mechanisms, and whether these subsets might be effectively identified and treated. In addition, many aspects of parkin-linked disease, originally thought to be well defined, have now been obscured both by genetic studies that preclude a simple model of disease transmission and by clinical and pathological studies that demonstrate broad variability in cases with parkin mutations. Future studies that address the issues in question should have a far-reaching impact in downstream biochemical studies and our understanding of parkin's role in PD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14727181     DOI: 10.1007/s00439-003-1074-6

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  65 in total

Review 1.  Epidemiology of Parkinson's disease and akinetic syndromes.

Authors:  C M Tanner; D A Aston
Journal:  Curr Opin Neurol       Date:  2000-08       Impact factor: 5.710

2.  Parkin: a multipurpose neuroprotective agent?

Authors:  Mel B Feany; Leo J Pallanck
Journal:  Neuron       Date:  2003-04-10       Impact factor: 17.173

Review 3.  Levodopa--an exotoxin or a therapeutic drug?

Authors:  E Melamed; D Offen; A Shirvan; I Ziv
Journal:  J Neurol       Date:  2000-04       Impact factor: 4.849

4.  Complete genomic screen in Parkinson disease: evidence for multiple genes.

Authors:  W K Scott; M A Nance; R L Watts; J P Hubble; W C Koller; K Lyons; R Pahwa; M B Stern; A Colcher; B C Hiner; J Jankovic; W G Ondo; F H Allen; C G Goetz; G W Small; D Masterman; F Mastaglia; N G Laing; J M Stajich; B Slotterbeck; M W Booze; R C Ribble; E Rampersaud; S G West; R A Gibson; L T Middleton; A D Roses; J L Haines; B L Scott; J M Vance; M A Pericak-Vance
Journal:  JAMA       Date:  2001-11-14       Impact factor: 56.272

5.  The parkin gene is not involved in late-onset Parkinson's disease.

Authors:  R L Oliveri; M Zappia; G Annesi; D Bosco; F Annesi; P Spadafora; A A Pasqua; C Tomaino; G Nicoletti; D Pirritano; A Labate; A Gambardella; G Logroscino; G Manobianca; A Epifanio; L Morgante; G Savettieri; A Quattrone
Journal:  Neurology       Date:  2001-07-24       Impact factor: 9.910

6.  Lewy bodies and parkinsonism in families with parkin mutations.

Authors:  M Farrer; P Chan; R Chen; L Tan; S Lincoln; D Hernandez; L Forno; K Gwinn-Hardy; L Petrucelli; J Hussey; A Singleton; C Tanner; J Hardy; J W Langston
Journal:  Ann Neurol       Date:  2001-09       Impact factor: 10.422

7.  Segregation analysis of Parkinson disease revealing evidence for a major causative gene.

Authors:  N E Maher; L J Currie; A M Lazzarini; J B Wilk; C A Taylor; M H Saint-Hilaire; R G Feldman; L I Golbe; G F Wooten; R H Myers
Journal:  Am J Med Genet       Date:  2002-05-01

8.  Parkinsonism and neurofibrillary tangle pathology in pigmented nuclei.

Authors:  A H Rajput; R J Uitti; S Sudhakar; B Rozdilsky
Journal:  Ann Neurol       Date:  1989-06       Impact factor: 10.422

9.  Characterization of FRA6E and its potential role in autosomal recessive juvenile parkinsonism and ovarian cancer.

Authors:  Stacy R Denison; Gwen Callahan; Nicole A Becker; Leslie A Phillips; David I Smith
Journal:  Genes Chromosomes Cancer       Date:  2003-09       Impact factor: 5.006

10.  Polymorphism in the parkin gene in sporadic Parkinson's disease.

Authors:  M Wang; N Hattori; H Matsumine; T Kobayashi; H Yoshino; A Morioka; T Kitada; S Asakawa; S Minoshima; N Shimizu; Y Mizuno
Journal:  Ann Neurol       Date:  1999-05       Impact factor: 10.422

View more
  25 in total

1.  Parkin mono-ubiquitinates Bcl-2 and regulates autophagy.

Authors:  Dong Chen; Feng Gao; Bin Li; Hongfeng Wang; Yuxia Xu; Cuiqing Zhu; Guanghui Wang
Journal:  J Biol Chem       Date:  2010-10-02       Impact factor: 5.157

2.  Parkin mediates the degradation-independent ubiquitination of Hsp70.

Authors:  Darren J Moore; Andrew B West; Dustin A Dikeman; Valina L Dawson; Ted M Dawson
Journal:  J Neurochem       Date:  2008-02-01       Impact factor: 5.372

3.  Drosophila overexpressing parkin R275W mutant exhibits dopaminergic neuron degeneration and mitochondrial abnormalities.

Authors:  Cheng Wang; Ruifeng Lu; Xuezhi Ouyang; Michelle W L Ho; William Chia; Fengwei Yu; Kah-Leong Lim
Journal:  J Neurosci       Date:  2007-08-08       Impact factor: 6.167

4.  Tauroursodeoxycholic Acid Improves Motor Symptoms in a Mouse Model of Parkinson's Disease.

Authors:  Alexandra Isabel Rosa; Sara Duarte-Silva; Anabela Silva-Fernandes; Maria João Nunes; Andreia Neves Carvalho; Elsa Rodrigues; Maria João Gama; Cecília Maria Pereira Rodrigues; Patrícia Maciel; Margarida Castro-Caldas
Journal:  Mol Neurobiol       Date:  2018-04-12       Impact factor: 5.590

Review 5.  The role of parkin in familial and sporadic Parkinson's disease.

Authors:  Ted M Dawson; Valina L Dawson
Journal:  Mov Disord       Date:  2010       Impact factor: 10.338

6.  Dietary management and physical exercise can improve climbing defects and mitochondrial activity in Drosophila melanogaster parkin null mutants.

Authors:  Rijan Bajracharya; J William O Ballard
Journal:  Fly (Austin)       Date:  2018-08-01       Impact factor: 2.160

7.  Differential expression of splice variant and wild-type parkin in sporadic Parkinson's disease.

Authors:  E K Tan; H Shen; J M M Tan; K L Lim; S Fook-Chong; W P Hu; M C Paterson; V R Chandran; K Yew; C Tan; Y Yuen; R Pavanni; M C Wong; K Puvan; Y Zhao
Journal:  Neurogenetics       Date:  2005-08-06       Impact factor: 2.660

8.  Parkin-mediated K63-polyubiquitination targets ubiquitin C-terminal hydrolase L1 for degradation by the autophagy-lysosome system.

Authors:  Jeanne E McKeon; Di Sha; Lian Li; Lih-Shen Chin
Journal:  Cell Mol Life Sci       Date:  2014-11-18       Impact factor: 9.261

9.  Parkin reinvents itself to regulate fatty acid metabolism by tagging CD36.

Authors:  Nada A Abumrad; Darren J Moore
Journal:  J Clin Invest       Date:  2011-08-25       Impact factor: 14.808

Review 10.  Animal models of Parkinson's disease progression.

Authors:  Gloria E Meredith; Patricia K Sonsalla; Marie-Francoise Chesselet
Journal:  Acta Neuropathol       Date:  2008-02-14       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.